Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Ballinger

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1995
Differences between accumulation of 99mTc-MIBI and 201Tl-thallous chloride in tumour cells: role of P-glycoproteinJ R Ballinger, K M Sheldon, I Boxen, et al.
Magnetic Resonance in Medicine|November 1, 1993
A potentially artifact-free oral contrast agent for gastrointestinal MRIT Liebig, C Stoupis, P R Ros, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Optimized radiolabelling of pig granulocytes with indium-111 tropolonateJ M Triandafillou, B Fair, V Petrovic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Regional differences in technetium-99m-ECD clearance on brain SPECT in healthy subjectsM Ichise, H Golan, J R Ballinger, et al.
Nuclear Medicine and Biology|January 11, 2001
A solid-phase technique for preparation of no-carrier-added technetium-99m radiopharmaceuticals: application to the streptavidin/biotin systemR Dunn-Dufault, A Pollak, J Fitzgerald, et al.
Nuclear Medicine Communications|April 1, 1995
99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variantJ R Ballinger, H A Hua, B W Berry, et al.
Magnetic Resonance Imaging|January 1, 1994
31P changes as a measure of therapy response in human osteosarcomas implanted into nude miceH Kang, J R Ballinger, C Sweeney, et al.
The British Journal of Cancer. Supplement|July 1, 1996
BMS181321 accumulation in rodent and human cells: the role of P-glycoproteinD S Cowan, T Melo, L Park, et al.
Clinical Nuclear Medicine|March 1, 1988
Technetium-99m red blood cell labeling in patients treated with doxorubicinJ R Ballinger, B Gerson, K Y Gulenchyn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1993
Effect of hypoxia on the accumulation of technetium-99m-glucarate and technetium-99m-gluconate by Chinese hamster ovary cells in vitroJ R Ballinger, D S Cowan, I Boxen, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1995
Differences between accumulation of 99mTc-MIBI and 201Tl-thallous chloride in tumour cells: role of P-glycoproteinJ R Ballinger, K M Sheldon, I Boxen, et al.
Magnetic Resonance in Medicine|November 1, 1993
A potentially artifact-free oral contrast agent for gastrointestinal MRIT Liebig, C Stoupis, P R Ros, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Optimized radiolabelling of pig granulocytes with indium-111 tropolonateJ M Triandafillou, B Fair, V Petrovic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Regional differences in technetium-99m-ECD clearance on brain SPECT in healthy subjectsM Ichise, H Golan, J R Ballinger, et al.
Nuclear Medicine and Biology|January 11, 2001
A solid-phase technique for preparation of no-carrier-added technetium-99m radiopharmaceuticals: application to the streptavidin/biotin systemR Dunn-Dufault, A Pollak, J Fitzgerald, et al.
Nuclear Medicine Communications|April 1, 1995
99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variantJ R Ballinger, H A Hua, B W Berry, et al.
Magnetic Resonance Imaging|January 1, 1994
31P changes as a measure of therapy response in human osteosarcomas implanted into nude miceH Kang, J R Ballinger, C Sweeney, et al.
The British Journal of Cancer. Supplement|July 1, 1996
BMS181321 accumulation in rodent and human cells: the role of P-glycoproteinD S Cowan, T Melo, L Park, et al.
Clinical Nuclear Medicine|March 1, 1988
Technetium-99m red blood cell labeling in patients treated with doxorubicinJ R Ballinger, B Gerson, K Y Gulenchyn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1993
Effect of hypoxia on the accumulation of technetium-99m-glucarate and technetium-99m-gluconate by Chinese hamster ovary cells in vitroJ R Ballinger, D S Cowan, I Boxen, et al.
Pageof 9